Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 4212
Gene Symbol: MEIS2
MEIS2
0.430 GeneticVariation disease BEFREE Myeloid ecotropic insertion site 2 (MEIS2) gene, encoding a homeodomain-containing transcription factor, has been recently related to syndromic intellectual disability with cleft palate and cardiac defects. 30735726 2020
Entrez Id: 7043
Gene Symbol: TGFB3
TGFB3
0.390 GeneticVariation disease BEFREE SMAD2 overexpression rescues the TGF-β3 null mutant mice cleft palate by increased apoptosis. 31677482 2020
Entrez Id: 10736
Gene Symbol: SIX2
SIX2
0.010 GeneticVariation disease BEFREE The low penetrance of clefting in the Six2 null mouse combined with the mutation in one patient with cleft palate underscores the potential combinatorial interactions of other genes in clefting. 31765609 2020
Entrez Id: 100505887
Gene Symbol: LINC01672
LINC01672
0.010 AlteredExpression disease BEFREE This research is trying to clarify the underlying mechanism of the modulation of miRNA transcription during the formation of cleft palate by 7T and 9.4T NMR metabolomic platforms. 31770533 2020
Entrez Id: 6093
Gene Symbol: ROCK1
ROCK1
0.010 Biomarker disease BEFREE ROCK1 is associated with non-syndromic cleft palate. 31715657 2020
Entrez Id: 4087
Gene Symbol: SMAD2
SMAD2
0.010 AlteredExpression disease BEFREE SMAD2 overexpression rescues the TGF-β3 null mutant mice cleft palate by increased apoptosis. 31677482 2020
Entrez Id: 406899
Gene Symbol: MIR106A
MIR106A
0.010 Biomarker disease BEFREE MiR-106a-5p modulates apoptosis and metabonomics changes by TGF-β/Smad signaling pathway in cleft palate. 31770533 2020
Entrez Id: 23314
Gene Symbol: SATB2
SATB2
0.890 Biomarker disease BEFREE SATB2-associated syndrome is one example of a syndromic cleft palate that is accompanied by intellectual disability, and various dental anomalies. 30848049 2019
Entrez Id: 3664
Gene Symbol: IRF6
IRF6
0.700 Biomarker disease BEFREE The disruption of IRF6 resulted in abnormal orofacial development including micrognathia and intraoral adhesions as well as tongue-palate fusion, then resulting in glossoptosis with airway obstruction and cleft palate. 29708799 2019
Entrez Id: 23327
Gene Symbol: NEDD4L
NEDD4L
0.620 GeneticVariation disease BEFREE Thus, the title should read "A missense mutation in the HECT domain of NEDD4L identified in a girl with periventricular nodular heterotopia, polymicrogyria, and cleft palate." 31028281 2019
Entrez Id: 50945
Gene Symbol: TBX22
TBX22
0.490 PosttranslationalModification disease BEFREE DNA hypermethylation of Fgf16 and Tbx22 associated with cleft palate during palatal fusion. 31596367 2019
Entrez Id: 8626
Gene Symbol: TP63
TP63
0.450 AlteredExpression disease BEFREE This process is driven by TGFβ3-mediated, down-regulation of p63 in the medial edge epithelia which allows periderm migration out of the midline epithelial seam and reduces the proliferative potential of the midline epithelial seam thereby preventing cleft palate. 28803895 2019
Entrez Id: 2260
Gene Symbol: FGFR1
FGFR1
0.450 Biomarker disease BEFREE Fibroblast growth factor receptor 1 (Fgfr1) plays a pivotal role in craniofacial bone development, and loss of Fgfr1 leads to cleft palate and facial cleft defects in newborn mice. 30499042 2019
Entrez Id: 1822
Gene Symbol: ATN1
ATN1
0.400 Biomarker disease GENOMICS_ENGLAND De Novo Variants Disrupting the HX Repeat Motif of ATN1 Cause a Recognizable Non-Progressive Neurocognitive Syndrome. 30827498 2019
Entrez Id: 23057
Gene Symbol: NMNAT2
NMNAT2
0.300 Biomarker disease GENOMICS_ENGLAND Severe biallelic loss-of-function mutations in nicotinamide mononucleotide adenylyltransferase 2 (NMNAT2) in two fetuses with fetal akinesia deformation sequence. 31136762 2019
Entrez Id: 57822
Gene Symbol: GRHL3
GRHL3
0.150 Biomarker disease BEFREE In addition to new associations, we found loci with subtype-specific effects (e.g., GRHL3 [CP], WNT5A [CLP]), as well as loci associated with two or all three subtypes. 31172578 2019
Entrez Id: 6774
Gene Symbol: STAT3
STAT3
0.110 Biomarker disease BEFREE Furthermore, the rescue of the mutant cleft palate using folic acid might highlight potential therapeutic targets aimed at Stat3 modification for the prevention and pharmaceutical intervention of cleft palate. 31171577 2019
Entrez Id: 7994
Gene Symbol: KAT6A
KAT6A
0.110 GeneticVariation disease BEFREE Among the more than 500 genes differentially expressed after loss of MOZ, 19 genes had previously been associated with cleft palates. 31340933 2019
Entrez Id: 4088
Gene Symbol: SMAD3
SMAD3
0.110 Biomarker disease BEFREE These results demonstrate that LEF1 and SMAD3 inhibits EMT at the MEE through the Hippo signaling pathway; and that this could contribute to cleft palate formation in embryonic palatal fusion at E 14.5. 30767676 2019
Entrez Id: 22858
Gene Symbol: CILK1
CILK1
0.110 Biomarker disease BEFREE Using Ick-mutant mice, we investigated the mechanisms by which ICK function loss causes cleft palate and examined pharmacological rescue of the congenital defects. 31662288 2019
Entrez Id: 93377
Gene Symbol: OPALIN
OPALIN
0.100 GeneticVariation disease GWASCAT Genomic analyses in African populations identify novel risk loci for cleft palate. 30452639 2019
Entrez Id: 6822
Gene Symbol: SULT2A1
SULT2A1
0.100 GeneticVariation disease GWASCAT Genomic analyses in African populations identify novel risk loci for cleft palate. 30452639 2019
Entrez Id: 105375475
Gene Symbol: LINC02476
LINC02476
0.100 GeneticVariation disease GWASCAT Genomic analyses in African populations identify novel risk loci for cleft palate. 30452639 2019
Entrez Id: 8048
Gene Symbol: CSRP3
CSRP3
0.040 Biomarker disease BEFREE One hundred thirty primary CL repairs (isolated CL = 59; cleft lip and palate [CLP] = 71) and 140 primary CP repairs (isolated CP = 72; CLP = 69): At the first postoperative visit, 21.54% of CL and 57.14% of CP repair patients had not returned to their immediate preoperative weights ( P < .0001). 29742363 2019
Entrez Id: 8048
Gene Symbol: CSRP3
CSRP3
0.040 AlteredExpression disease BEFREE Cleft lip (CL) has increased from 17.4% in 2014 to 34.2% in 2017, cleft palate (CP) has decreased from 32.9% to 20.2%; and CLP changed from 49.6% to 45.5% in the same period. 31795734 2019